Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine
ConditionMonkeypox
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
This study is to evaluate the long-term immunogenicity of a boost dose of MVA-BN vaccine
Eligibility criteria
Qualifiers
Men aged over 18 years
Have received two doses of MVA-BN vaccine as an initial schedule
Eligible for a booster dose of MVA-BN (according to the HAS recommendation)
Be eligible and wish to initiate PrEP-HIV treatment or be followed for PrEP-HIV treatment
Disqualifiers
History of mpox (virologically confirmed)
Be under guardianship or curatorship
Be subject to a judicial protection measure
Have a contraindication to vaccination against mpox
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov